NO882281D0 - Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.Info
- Publication number
- NO882281D0 NO882281D0 NO882281A NO882281A NO882281D0 NO 882281 D0 NO882281 D0 NO 882281D0 NO 882281 A NO882281 A NO 882281A NO 882281 A NO882281 A NO 882281A NO 882281 D0 NO882281 D0 NO 882281D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrazinamides
- procedure
- preparation
- therapeutic active
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878712365A GB8712365D0 (en) | 1987-05-26 | 1987-05-26 | Aminomethylphenolic pyrazines |
| GB888804983A GB8804983D0 (en) | 1988-03-02 | 1988-03-02 | Heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO882281D0 true NO882281D0 (no) | 1988-05-25 |
| NO882281L NO882281L (no) | 1988-11-28 |
Family
ID=26292286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO882281A NO882281L (no) | 1987-05-26 | 1988-05-25 | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4910202A (no) |
| EP (1) | EP0293170A1 (no) |
| JP (1) | JPS6456668A (no) |
| KR (1) | KR880013904A (no) |
| CN (1) | CN88103114A (no) |
| AU (1) | AU1634588A (no) |
| DK (1) | DK288888A (no) |
| FI (1) | FI882482A (no) |
| GB (1) | GB8810933D0 (no) |
| HU (1) | HU199129B (no) |
| NO (1) | NO882281L (no) |
| PL (1) | PL272681A1 (no) |
| PT (1) | PT87572B (no) |
| ZW (1) | ZW6388A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810934D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Amides |
| US5739211A (en) * | 1997-02-25 | 1998-04-14 | The Goodyear Tire & Rubber Company | Rubber compositions containing a pyrazine amide |
| US6486350B1 (en) | 1998-09-30 | 2002-11-26 | Elan Pharmaceuticals Inc. | Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide |
| KR20110040818A (ko) * | 2008-06-10 | 2011-04-20 | 노파르티스 아게 | 상피 나트륨 채널 차단제로서의 피라진 유도체 |
| UY36034A (es) | 2014-03-18 | 2015-09-30 | Astrazeneca Ab | Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3305552A (en) * | 1965-11-22 | 1967-02-21 | Merck & Co Inc | 3-aminopyrazinoic acids and process for their preparation |
| NL6707566A (no) * | 1966-08-17 | 1968-02-19 | ||
| US3555024A (en) * | 1968-11-13 | 1971-01-12 | Merck & Co Inc | 1-(3-aminopyrazinoyl)semicarbazides,1-(3-aminopyrazinoyl) - thiosemicarbazides,and method for their preparation |
| US3567725A (en) * | 1968-11-20 | 1971-03-02 | Merck & Co Inc | Process for preparation of 1h-imidazo-(4,5-b)pyrazin-2-ones |
| US3577418A (en) * | 1969-02-12 | 1971-05-04 | Merck & Co Inc | Pyrazinamide derivatives and processes for their preparation |
| US3544568A (en) * | 1969-03-18 | 1970-12-01 | Merck & Co Inc | 3-amino-5,6-substituted pyrazinamides |
| US3809721A (en) * | 1970-12-23 | 1974-05-07 | Merck & Co Inc | Substituted 2-aminomethyl-4,6-disubstituted phenols |
| US4041032A (en) * | 1974-01-16 | 1977-08-09 | Yamanouchi Pharmaceutical Co., Ltd. | Pyrazine derivatives |
| US3928624A (en) * | 1974-04-25 | 1975-12-23 | Merck & Co Inc | Phenol compounds in treating pain, fever and inflammation |
| US4029816A (en) * | 1975-11-25 | 1977-06-14 | Merck & Co., Inc. | Substituted 2-aminomethyl-6-iodophenols |
| US4085211A (en) * | 1975-12-15 | 1978-04-18 | Merck & Co., Inc. | Pyrazinecarboxamides and processes for preparing same |
| US4115573A (en) * | 1977-03-04 | 1978-09-19 | Merck & Co., Inc. | N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same |
| US4272537A (en) * | 1980-07-02 | 1981-06-09 | Merck & Co., Inc. | 3-Amino-5-substituted-6-halo-N-(4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides |
| FI820266L (fi) * | 1981-02-02 | 1982-08-03 | Ici Plc | Alkanolaminderivater |
| US4550111A (en) * | 1982-01-29 | 1985-10-29 | Imperial Chemical Industries Plc | Alkanolamine derivatives |
-
1988
- 1988-05-09 GB GB888810933A patent/GB8810933D0/en active Pending
- 1988-05-16 ZW ZW63/88A patent/ZW6388A1/xx unknown
- 1988-05-17 AU AU16345/88A patent/AU1634588A/en not_active Abandoned
- 1988-05-24 EP EP88304696A patent/EP0293170A1/en not_active Ceased
- 1988-05-25 NO NO882281A patent/NO882281L/no unknown
- 1988-05-25 PL PL27268188A patent/PL272681A1/xx unknown
- 1988-05-25 HU HU882649A patent/HU199129B/hu not_active IP Right Cessation
- 1988-05-25 PT PT87572A patent/PT87572B/pt not_active IP Right Cessation
- 1988-05-26 CN CN198888103114A patent/CN88103114A/zh active Pending
- 1988-05-26 DK DK288888A patent/DK288888A/da not_active Application Discontinuation
- 1988-05-26 FI FI882482A patent/FI882482A/fi not_active Application Discontinuation
- 1988-05-26 JP JP63129418A patent/JPS6456668A/ja active Pending
- 1988-05-26 KR KR1019880006198A patent/KR880013904A/ko not_active Application Discontinuation
- 1988-05-26 US US07/198,946 patent/US4910202A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUT47918A (en) | 1989-04-28 |
| ZW6388A1 (en) | 1989-12-20 |
| CN88103114A (zh) | 1988-12-28 |
| JPS6456668A (en) | 1989-03-03 |
| US4910202A (en) | 1990-03-20 |
| DK288888A (da) | 1988-11-27 |
| KR880013904A (ko) | 1988-12-22 |
| EP0293170A1 (en) | 1988-11-30 |
| FI882482A0 (fi) | 1988-05-26 |
| DK288888D0 (da) | 1988-05-26 |
| NO882281L (no) | 1988-11-28 |
| FI882482A (fi) | 1988-11-27 |
| PT87572B (pt) | 1992-09-30 |
| HU199129B (en) | 1990-01-29 |
| PT87572A (pt) | 1989-05-31 |
| GB8810933D0 (en) | 1988-06-15 |
| PL272681A1 (en) | 1989-02-06 |
| AU1634588A (en) | 1988-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO884154L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
| NO871267D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO871277D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler. | |
| NO875082L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer. | |
| NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO884473L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO871588L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. | |
| NO883750L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO883485L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO880667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO883959D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
| NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |